Cardiovascular Disease Risk in Women With Endometriosis (NCT03746535)

🧪 Interventions in This Study

• Elagolix (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Yale School of Medicine — New Haven, Connecticut

📞 Contact the Study Coordinator

Phone: (203) 562-9901

Email: nina.stachenfeld@yale.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Endometriosis

• Nutritional Intervention for Endometriosis — Washington D.C., District of Columbia
• Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI — Chapel Hill, North Carolina
• Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain — Anniston, Alabama
• The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA — Palo Alto, California
• Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance — New Haven, Connecticut
• Endometriosis and Health Care System Utilization in British Columbia — Vancouver, British Columbia

Explore by condition: All Endometriosis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.